Jonathan Kafer

Jonathan Kafer has held various executive positions in the pharmaceutical industry, including Vice President roles at Geneva Pharmaceuticals, AAIPharma, Xanodyne Pharmaceuticals, Teva Pharmaceuticals, Allergan, and Akorn Pharmaceuticals. Currently, Jonathan serves as President of LumaCina and Chief Commercial Officer at Bridgewest Pharma. Jonathan's expertise lies in developing channel strategies, leading sales and marketing functions, and overseeing customer-facing account teams across different therapeutic areas such as Oncology, Eye Care, Neurology, Medical Dermatology, and Urology. Jonathan studied at The Ohio State University.